Pi-Cardia's ShortCut™ device is the first FDA-cleared leaflet modification technology designed to enable valve-in-valve TAVR procedures in patients at risk of coronary obstruction.
Pi-Cardia's ShortCut™ device is the first FDA-cleared leaflet modification technology designed to enable valve-in-valve TAVR procedures in patients at risk of coronary obstruction.
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
A world-first clinical trial conducted by Monash University researchers has shown that cholesterol-lowering medication can reduce heart attack and stroke in people aged over 70 years.
A world-first clinical trial conducted by Monash University researchers has shown that cholesterol-lowering medication can reduce heart attack and stroke in people aged over 70 years.
MUNICH -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, announced new independent University of Oxford-led research presented at the European Society of Cardiology (ESC) Congress 2026 showing that...
MUNICH -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, announced new independent University of Oxford-led research presented at the European Society of Cardiology (ESC) Congress 2026 showing that...
Many people who survive a heart attack will later develop heart failure due to the scarring that occurs as the heart heals. Researchers at Uppsala University are now presenting a new type of biological treatment that is administered directly...
Many people who survive a heart attack will later develop heart failure due to the scarring that occurs as the heart heals. Researchers at Uppsala University are now presenting a new type of biological treatment that is administered directly...
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
Key takeaways
Whether immediate coronary angiography should be performed routinely in unconscious patients without an ECG ST-elevation after out-of-hospital cardiac arrest is uncertain due to the lack of data...
Key takeaways
Whether immediate coronary angiography should be performed routinely in unconscious patients without an ECG ST-elevation after out-of-hospital cardiac arrest is uncertain due to the lack of data...
The open-label, noninferiority ISOLEDS trial enrolled 664 patients with true distal left main bifurcation lesions at 24 centres in China and randomised them (1:1) to OCT- or IVUS-guided PCI.
The open-label, noninferiority ISOLEDS trial enrolled 664 patients with true distal left main bifurcation lesions at 24 centres in China and randomised them (1:1) to OCT- or IVUS-guided PCI.
This open-label noninferiority trial was conducted at 25 French centres. Patients aged 80 years or older who were hospitalised with NSTEMI were included. They were randomised to receive either stress imaging-guided selective invasive...
This open-label noninferiority trial was conducted at 25 French centres. Patients aged 80 years or older who were hospitalised with NSTEMI were included. They were randomised to receive either stress imaging-guided selective invasive...
Key takeaways
Statins are highly effective at preventing atherosclerotic cardiovascular disease but selecting which patients are most at risk and should receive statins can be challenging.
The CorCal Outcomes trial...
Key takeaways
Statins are highly effective at preventing atherosclerotic cardiovascular disease but selecting which patients are most at risk and should receive statins can be challenging.
The CorCal Outcomes trial...
